Technical Analysis for BBLGW - Bone Biologics Corp - warrants
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Sell Signal | Bearish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | -20.09% | |
| Wide Bands | Range Expansion | -20.09% | |
| Overbought Stochastic | Strength | -20.09% | |
| Narrow Range Bar | Range Contraction | -20.09% | |
| Inside Day | Range Contraction | -20.09% |
| Alert | Time |
|---|---|
| Down 5% | about 8 hours ago |
| Down 3% | about 8 hours ago |
| Fell Below Previous Day's Low | about 8 hours ago |
| Down 2 % | about 8 hours ago |
| Down 1% | about 8 hours ago |
Get a Trading Sidekick!
- Earnings date: Unknown
Bone Biologics Corp - warrants Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biopharmaceutical Neurosurgery Platform Technology Orthopedic Surgery Sports Medicine Surgical Specialties Spinal Fusion Degenerative Disc Disease Neurosurgical Procedures Spinal Fusion Applications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 44.145 |
| 52 Week Low | 0.4334 |
| Average Volume | 1,537 |
| 200-Day Moving Average | 7.23 |
| 50-Day Moving Average | 15.48 |
| 20-Day Moving Average | 18.13 |
| 10-Day Moving Average | 22.46 |
| Average True Range | 1.92 |
| RSI (14) | 50.50 |
| ADX | 18.34 |
| +DI | 42.33 |
| -DI | 47.66 |
| Chandelier Exit (Long, 3 ATRs) | 19.25 |
| Chandelier Exit (Short, 3 ATRs) | 14.76 |
| Upper Bollinger Bands | 28.40 |
| Lower Bollinger Band | 7.87 |
| Percent B (%b) | 0.54 |
| BandWidth | 113.22 |
| MACD Line | 2.07 |
| MACD Signal Line | 1.96 |
| MACD Histogram | 0.1164 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 19.01 | ||||
| Resistance 3 (R3) | 19.01 | 19.01 | 19.01 | ||
| Resistance 2 (R2) | 19.01 | 19.01 | 19.01 | 19.01 | |
| Resistance 1 (R1) | 19.01 | 19.01 | 19.01 | 19.01 | 19.01 |
| Pivot Point | 19.01 | 19.01 | 19.01 | 19.01 | 19.01 |
| Support 1 (S1) | 19.01 | 19.01 | 19.01 | 19.01 | 19.01 |
| Support 2 (S2) | 19.01 | 19.01 | 19.01 | 19.01 | |
| Support 3 (S3) | 19.01 | 19.01 | 19.01 | ||
| Support 4 (S4) | 19.01 |
